By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has entered into a supply and distribution deal with privately held Cancer Genetics (CGI) covering the use of Enzo Life Sciences' fluorescent dye labels for increasing signal intensity in labeling nucleic acids.

Under the non-exclusive agreement, Enzo Life Sciences will incorporate its labels into CGI's nucleic acid material that it and supplies to the research market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.